Schrodinger Inc (SDGR) is a Healthcare · Health Information Services company listed on NASDAQ. Price $29.21 (-3.41%), Market cap $0.89B, 52-week low–high $11.07 ~ $26.69.
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multip
Financial statements, price targets, institutional (13F) holdings and related news for Schrodinger Inc are updated in real time on BlackAll Trade.
Schrodinger Inc trades at $29.21 (-3.41%). Real-time quotes and charts are available on BlackAll Trade.
Schrodinger Inc has a market cap of about $0.89B.
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United